SEATTLE GENETICS INC (76) | Supply Agreements (9)
Recent Contracts
-
Amendment No. 1 to Commercial Supply Agreement dated June 17, 2022 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Corden Pharma GmbH
(Filed With SEC on July 28, 2022)
-
Commercial Supply Agreement between Hovione Farmaciencia, SA and Seagen Inc. dated July 1, 2021
(Filed With SEC on October 28, 2021)
-
Commercial Supply Agreement dated December 1, 2010 between
(Filed With SEC on February 12, 2021)
-
First Amendment to Commercial Supply Agreement effective as of January 20, 2014 between
(Filed With SEC on February 12, 2021)
-
Second Amendment to Commercial Supply Agreement effective as of December 2, 2016 between
(Filed With SEC on February 12, 2021)
-
Commercial Supply Agreement dated June 13, 2019 between Seattle Genetics, Inc. and Esteve Quimica, S.A
(Filed With SEC on July 31, 2020)
-
Commercial Supply Agreement dated February 20, 2020 between Seattle Genetics, Inc. and Corden Plankstadt
(Filed With SEC on July 31, 2020)
-
Commercial Supply Agreement dated April 2, 2020 between Seattle Genetics, Inc. and Sterling Pharma Solutions Limited
(Filed With SEC on July 31, 2020)
-
Third Amendment to Commercial Supply Agreement effective as of July 1, 2019 between Seattle Genetics, Inc. and SAFC, an operating division of Sigma-Aldrich, Inc
(Filed With SEC on October 30, 2019)